Cargando…
Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
Cardiovascular disease (CVD) has been the number one cause of death in the U.S. for 114 of the last 115 years. Lifestyle factors that promote CVD also appear to increase prostate cancer risk and those that reduce CVD risk also appear to reduce the risk of prostate cancer. The largest randomized tria...
Autores principales: | Moyad, Mark A, Vogelzang, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577591/ https://www.ncbi.nlm.nih.gov/pubmed/25657084 http://dx.doi.org/10.4103/1008-682X.148070 |
Ejemplares similares
-
Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
por: Koo, Hye Yeon, et al.
Publicado: (2021) -
Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021) -
Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
por: Olivan, M., et al.
Publicado: (2015) -
Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy
por: Gash, K J, et al.
Publicado: (2017) -
Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)